Floatz logo

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE

Oral Mucositis

US Oncology ResearchSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Oral Mucositis cohort.

Asset / SponsorPhaseRating
Solu-Cortef
US Oncology Research
Phase 2B
Mit-001
MitoImmune Therapeutics
Phase 2CCC
Losartan
Ain Shams University
Phase 2CCC
Sodium Chloride
Vejle Hospital
N/AD
ZINC SULFATE
National Institute of Pediatrics, Mexico
N/AD
Ankaferd Blood Stopper
Uludag University
N/AD
Evomela
Sherif S. Farag
D
BICARBONATE ION
Uludag University
N/AD

Same molecule, other indications

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:

infantile spasmsDormant
BBB
Indicative ·
79 / 100
View asset →
non-Hodgkin lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
castration-resistant prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →